RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.

Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.

Add to Collection
2013 Others Fist_Author_Year_PM

Full Author : ['Patel, Vishal', 'Joharapurkar, Amit', 'Dhanesha, Nirav', 'Kshirsagar, Samadhan', 'Detroja, Jaysukh', 'Patel, Kartikkumar', 'Gandhi, Tejal', 'Patel, Kirti', 'Bahekar, Rajesh', 'Jain, Mukul']
Journal Title : Pharmacological reports : PR
Chapter : Section3
Journal Year : 2013
Cited by : Not Available

BACKGROUND: Combination with suitable pharmacological agents can improve the antiobesity and antidiabetic actions of glucagon like peptide-1 (GLP-1) based therapies. GLP-1 agonist exendin-4 may have insulin-independent effects on amelioration of insulin r.....

Keywords : ["agonist therapy improve insulin sensitivity", "type diabetic mouse", "antioxidant activity", "omeprazole", "liver", "combination"]